New products: Rybelsus (semaglutide) 3, 7 and 14mg tablets

Semaglutide, a glucagon-like peptide-1 analogue is licensed for treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise.

electronic Medicines compendium